A RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDY OF OLEZARSEN IN PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME

Category Primary study
JournalJournal of the American College of Cardiology
Year 2024
This article has no abstract
Epistemonikos ID: cd940a37ac025e35dc88332f200aaa1410130575
First added on: Feb 17, 2025